(1)
Likhar, R. V.; Joshi, S. Recent Development of Heterocyclic Scaffolds As EGFR Kinase Inhibitors in Cancer. Curr. Issues Pharm. Med. Sci. 2025, 38 (2), 112-121. https://doi.org/10.12923/cipms-2025-0018.